Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.31

-$0.04 (-0.75%)

At close: Oct 30, 2026, 4:00 PM ET

$5.49

+$0.18 (+3.39%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.75%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

23.8

+0.6 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #950/1028 (Top 92%)

Full Analysis

Key Statistics

Market Data

Market Cap $287.48M

1D Range

5.01 5.40

52W Range

5.01 16.26

Valuation (TTM)

PE -1.15

PB 0.62

EV/EBITDA -0.03

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target $14.00

Cash Flow

FCF Yield -90.2%

SBC Adj. FCF Yield -92.9%

SBC Impact -3.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -41.3%

ROE 193.4%

ROIC -46.2%

Financial Health

Net Cash

$522.13M

Current Ratio 9.89

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to develop...

Sector Healthcare

Industry Biotechnology

Employees 384

IPO Date Feb 5, 2026

Website eikontx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Sell

Price Target

$14.00

Upside

+163.65%

Buy (0)

Hold (0)

Sell (1)

Analyst Details ➞